StockNews.com started coverage on shares of IRIDEX (NASDAQ:IRIX – Free Report) in a report issued on Thursday morning. The brokerage issued a hold rating on the medical equipment provider’s stock.
IRIDEX Price Performance
NASDAQ IRIX opened at $1.52 on Thursday. IRIDEX has a 12 month low of $1.45 and a 12 month high of $3.65. The firm has a market capitalization of $24.70 million, a PE ratio of -2.30 and a beta of 0.78. The company’s 50 day simple moving average is $1.82 and its 200 day simple moving average is $2.20.
IRIDEX (NASDAQ:IRIX – Get Free Report) last issued its quarterly earnings results on Thursday, August 8th. The medical equipment provider reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by ($0.04). IRIDEX had a negative net margin of 21.84% and a negative return on equity of 134.37%. The firm had revenue of $12.63 million for the quarter, compared to analyst estimates of $12.80 million. During the same quarter last year, the business posted ($0.17) earnings per share. Sell-side analysts anticipate that IRIDEX will post -0.52 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
IRIDEX Company Profile
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.
Recommended Stories
- Five stocks we like better than IRIDEX
- Learn Technical Analysis Skills to Master the Stock Market
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- What Does Downgrade Mean in Investing?
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
- There Are Different Types of Stock To Invest In
- The Downtrend in UPS Stock Isn’t Over Yet
Receive News & Ratings for IRIDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IRIDEX and related companies with MarketBeat.com's FREE daily email newsletter.